A closer look at the technologies used by Synairgen
See more technologies
Synairgen
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Level F South Block Southampton General ...Phone Number
+44 2380512800Website
www.synairgen.comRevenue
$12.2 MillionStock Symbol
SNGIndustry
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Synairgen
Compare insights from companies similar to Synairgen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Synairgen
$12.2M
11-50
Public
$34.5M
2003
N/A
Synairgen Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Synairgen
Sign Up For FreeTo access detailed company insights
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses.... Read More
